FBLN1 and hepatocellular carcinoma: Importantly, the Fibulin-1 levels were also increased in patients with HCC (54.51 ± 73.47) compared with that in patients with cirrhosis (22.93 ± 16.87) and that in patients with chronic hepatitis B (11.53 ± 10.76) (Figure 7A).